Wolverine Trading, LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Wolverine Trading, LLC

  • $94.2 Billion
  • Q2 2024

Call Options

25 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$83.81 - $99.0 $1.34 Million - $1.58 Million
16,000 New
16,000 $1.4 Million
Q3 2023

Nov 15, 2023
BUY
$85.07 - $94.48 $723,095 - $803,080
8,500 Added 35.42%
32,500 $2.88 Million
Q2 2023

Aug 23, 2023
SELL
$86.68 - $100.3 $1.07 Million - $1.23 Million
-12,300 Reduced 33.88%
24,000 $2.08 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $1.31 Million - $1.75 Million
14,900 Added 69.63%
36,300 $3.46 Million
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $865,951 - $1.16 Million
10,700 Added 100.0%
21,400 $2.22 Million
Q3 2022

Nov 14, 2022
BUY
$82.16 - $96.94 $41,080 - $48,470
500 Added 4.9%
10,700 $910,000
Q2 2022

Aug 15, 2022
BUY
$71.48 - $86.85 $50,036 - $60,794
700 Added 7.37%
10,200 $856,000
Q1 2022

May 16, 2022
SELL
$74.28 - $92.69 $631,380 - $787,865
-8,500 Reduced 47.22%
9,500 $740,000
Q4 2021

Feb 14, 2022
SELL
$71.72 - $91.47 $609,620 - $777,495
-8,500 Reduced 32.08%
18,000 $1.6 Million
Q3 2021

Nov 12, 2021
SELL
$74.77 - $85.47 $119,632 - $136,752
-1,600 Reduced 5.69%
26,500 $2.04 Million
Q2 2021

Aug 06, 2021
SELL
$75.51 - $84.79 $649,386 - $729,194
-8,600 Reduced 23.43%
28,100 $2.35 Million
Q1 2021

May 14, 2021
SELL
$74.73 - $90.69 $1.76 Million - $2.14 Million
-23,600 Reduced 39.14%
36,700 $2.75 Million
Q4 2020

Feb 12, 2021
SELL
$72.61 - $90.2 $747,883 - $929,060
-10,300 Reduced 14.59%
60,300 $5.24 Million
Q3 2020

Nov 13, 2020
BUY
$71.87 - $131.03 $1.66 Million - $3.03 Million
23,100 Added 48.63%
70,600 $5.37 Million
Q2 2020

Aug 13, 2020
BUY
$79.55 - $124.22 $763,680 - $1.19 Million
9,600 Added 25.33%
47,500 $5.8 Million
Q1 2020

May 11, 2020
SELL
$71.37 - $96.85 $1.24 Million - $1.69 Million
-17,400 Reduced 31.46%
37,900 $3.13 Million
Q4 2019

Feb 12, 2020
BUY
$64.27 - $86.37 $32,134 - $43,185
500 Added 0.91%
55,300 $4.68 Million
Q3 2019

Nov 14, 2019
BUY
$67.4 - $85.11 $3.69 Million - $4.66 Million
54,800 New
54,800 $3.74 Million
Q2 2019

Aug 20, 2019
SELL
$80.35 - $93.9 $2.82 Million - $3.3 Million
-35,100 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$84.2 - $98.62 $378,900 - $443,790
-4,500 Reduced 11.36%
35,100 $3.12 Million
Q4 2018

Feb 14, 2019
BUY
$80.14 - $106.07 $1.16 Million - $1.54 Million
14,500 Added 57.77%
39,600 $3.31 Million
Q3 2018

Nov 14, 2018
BUY
$93.92 - $105.72 $695,008 - $782,328
7,400 Added 41.81%
25,100 $2.43 Million
Q1 2018

May 15, 2018
SELL
$77.67 - $92.63 $295,146 - $351,994
-3,800 Reduced 17.67%
17,700 $1.44 Million
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $783,372 - $922,761
9,700 Added 82.2%
21,500 $1.92 Million
Q3 2017

Nov 15, 2017
BUY
$80.6 - $94.95 $951,079 - $1.12 Million
11,800
11,800 $1.1 Million

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email